| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:09:40 -0700 |
| HMDB ID |
HMDB00961 |
| Secondary Accession Numbers |
|
| Metabolite Identification |
| Common Name |
Farnesyl pyrophosphate |
| Description |
Farnesyl pyrophosphate is an intermediate in the HMG-CoA reductase pathway used by organisms in the biosynthesis of terpenes and terpenoids. -- Wikipedia. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (2E,6E)-Farnesyl diphosphate
- (2E,6E)-Farnesyl pyrophosphate
- (all-E)-Farnesyl diphosphate
- (E,E)-Farnesyl diphosphate
- (E,E)-Farnesyl pyrophosphate
- 2-trans,6-trans-Farnesyl diphosphate
- 2-trans,6-trans-Farnesyl pyrophosphate
- All-trans-Farnesyl pyrophosphate
- Farnesyl diphosphate
- Farnesyl pyrophosphate
- Farnesyl-PP
- trans-Farnesyl pyrophosphate
- trans-trans-Farnesyl diphosphate
- trans-trans-Farnesyl pyrophosphate
|
| Chemical Formula |
C15H28O7P2 |
| Average Molecular Weight |
382.3261 |
| Monoisotopic Molecular Weight |
382.131026274 |
| IUPAC Name |
{[hydroxy({[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy})phosphoryl]oxy}phosphonic acid |
| Traditional IUPAC Name |
{hydroxy[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxyphosphoryl}oxyphosphonic acid |
| CAS Registry Number |
13058-04-3 |
| SMILES |
CC(C)=CCC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O |
| InChI Identifier |
InChI=1S/C15H28O7P2/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-21-24(19,20)22-23(16,17)18/h7,9,11H,5-6,8,10,12H2,1-4H3,(H,19,20)(H2,16,17,18)/b14-9+,15-11+ |
| InChI Key |
VWFJDQUYCIWHTN-YFVJMOTDSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Lipids |
| Class |
Prenol Lipids |
| Sub Class |
Sesquiterpenes |
| Other Descriptors |
- Aliphatic Acyclic Compounds
- farnesyl phosphate(ChEBI)
- polyprenol diphosphate(ChEBI)
|
| Substituents |
- Acyclic Alkene
- Isoprene
- Organic Hypophosphite
- Organic Phosphite
- Organic Pyrophosphate
- Phosphoric Acid Ester
|
| Direct Parent |
Sesquiterpenes |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Cell signaling
- Component of Terpenoid biosynthesis
- Fuel and energy storage
- Fuel or energy source
- Membrane integrity/stability
|
| Application |
- Nutrients
- Stabilizers
- Surfactants and Emulsifiers
|
| Cellular locations |
- Cytoplasm
- Extracellular
- Membrane
- Endoplasmic reticulum
- Peroxisome
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
Not Available
|
| Biological Properties |
| Cellular Locations |
- Cytoplasm
- Extracellular
- Membrane
- Endoplasmic reticulum
- Peroxisome
|
| Biofluid Locations |
|
| Tissue Location |
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.0086 (0.0000-0.0170) uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
Not Available |
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB022339 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
393270  |
| KEGG Compound ID |
C00448  |
| BioCyc ID |
FARNESYL-PP  |
| BiGG ID |
35006  |
| Wikipedia Link |
Farnesyl pyrophosphate  |
| NuGOwiki Link |
HMDB00961  |
| Metagene Link |
HMDB00961  |
| METLIN ID |
403  |
| PubChem Compound |
445713  |
| PDB ID |
FPP  |
| ChEBI ID |
17407  |
| References |
| Synthesis Reference |
Castillo-Bocanegra, Rafael. Synthesis and biological activity of farnesyl pyrophosphate analogs. (1977), 193 pp. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Shellman YG, Ribble D, Miller L, Gendall J, Vanbuskirk K, Kelly D, Norris DA, Dellavalle RP: Lovastatin-induced apoptosis in human melanoma cell lines. Melanoma Res. 2005 Apr;15(2):83-9.
Pubmed: 15846140
- Argmann CA, Edwards JY, Sawyez CG, O'Neil CH, Hegele RA, Pickering JG, Huff MW: Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux. J Biol Chem. 2005 Jun 10;280(23):22212-21. Epub 2005 Apr 6.
Pubmed: 15817453
- Reigard SA, Zahn TJ, Haworth KB, Hicks KA, Fierke CA, Gibbs RA: Interplay of isoprenoid and peptide substrate specificity in protein farnesyltransferase. Biochemistry. 2005 Aug 23;44(33):11214-23.
Pubmed: 16101305
- Tacer KF, Haugen TB, Baltsen M, Debeljak N, Rozman D: Tissue-specific transcriptional regulation of the cholesterol biosynthetic pathway leads to accumulation of testis meiosis-activating sterol (T-MAS). J Lipid Res. 2002 Jan;43(1):82-9.
Pubmed: 11792726
- Saisho Y, Morimoto A, Umeda T: Determination of farnesyl pyrophosphate in dog and human plasma by high-performance liquid chromatography with fluorescence detection. Anal Biochem. 1997 Oct 1;252(1):89-95.
Pubmed: 9324945
- Sanders JM, Song Y, Chan JM, Zhang Y, Jennings S, Kosztowski T, Odeh S, Flessner R, Schwerdtfeger C, Kotsikorou E, Meints GA, Gomez AO, Gonzalez-Pacanowska D, Raker AM, Wang H, van Beek ER, Papapoulos SE, Morita CT, Oldfield E: Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption. J Med Chem. 2005 Apr 21;48(8):2957-63.
Pubmed: 15828834
- Notarnicola M, Messa C, Cavallini A, Bifulco M, Tecce MF, Eletto D, Di Leo A, Montemurro S, Laezza C, Caruso MG: Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis. Oncology. 2004;67(5-6):351-8.
Pubmed: 15713990
- Fukuchi J, Song C, Ko AL, Liao S: Transcriptional regulation of farnesyl pyrophosphate synthase by liver X receptors. Steroids. 2003 Sep;68(7-8):685-91.
Pubmed: 12957674
|